Who To Contact
Baptist MD Anderson
Cancer Center
1301 Palm Avenue
Jacksonville, FL 32207
Poonam K. Neki, MBBS,DA, CCRP
Research Director
Baptist MD Anderson Clinical Trials
904.202.7468
poonam.neki@bmcjax.com
Clinical Trial ID: NCT04622319
A Phase 3, Multicenter, Randomized, Open-Label, Active-Controlled Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in Subjects with High-Risk HER2-Positive Primary Breast Cancer Who Have Residual Invasive Disease in Breast or Axillary Lymph Nodes Following Neoadjuvant Therapy
Status
Open
Conditions
Other
Phases
III
Age Group
Adult
Main Investiagtor
Zuberi, Lara
Practice
Breast
Scope
National
Participating Institutions
Baptist MD Anderson Cancer Center
Nct ID Number
NCT04622319
Secondary Trial ID Number
B-60 (DS8201-A-U305); DS8201-A-U305/ DESTINY
Keywords
Treatment